Melanocortin receptor ligands

Details Melanocortin receptor ligands Melanocortin receptor ligands

2006-04-11

2006-04-11

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S208000, C546S210000

Reexamination Certificate

active

07026335

ABSTRACT:
The present invention relates to compounds which comprise a 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring. The compounds, including all enatiomeric and diasteriomeric forms and pharmaceutically acceptable salts thereof, have the formula:wherein preferably R is substituted aryl, W is a pendant unit having the formula:in-line-formulae description="In-line Formulae" end="lead"?-L-Qin-line-formulae description="In-line Formulae" end="tail"?L is a linking unit, Q is preferably a cyclic hydrocarbyl unit; W1is preferably a carbocyclic unit and W2is a heteroatom comprising unit.

REFERENCES:
patent: 5071859 (1991-12-01), Knudsen et al.
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5494919 (1996-02-01), Morriello et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5721251 (1998-02-01), Chen et al.
patent: 5783582 (1998-07-01), Guo et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5877182 (1999-03-01), Nargund et al.
patent: 5880125 (1999-03-01), Nargund
patent: 5936089 (1999-08-01), Carpino et al.
patent: 5965565 (1999-10-01), Chen et al.
patent: 6294534 (2001-09-01), Nargund et al.
patent: 6350760 (2002-02-01), Bakshi et al.
patent: 6767915 (2004-07-01), Bakshi et al.
patent: 2003/0092732 (2003-05-01), Yu et al.
patent: WO 94/13696 (1994-06-01), None
patent: WO 94/19367 (1994-09-01), None
patent: WO 96/02530 (1996-02-01), None
patent: WO 96/13265 (1996-05-01), None
patent: WO 96/38471 (1996-12-01), None
patent: WO 98/10653 (1998-03-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 99/58501 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/059107 (2002-08-01), None
patent: WO 02/059117 (2002-08-01), None
patent: WO 02/068387 (2002-09-01), None
patent: WO 02/068388 (2002-09-01), None
patent: WO 02/070511 (2002-09-01), None
patent: WO 03/013571 (2003-02-01), None
patent: WO 03/031410 (2003-04-01), None
Heckel et al. “Preparation of benzimidazolyalaniamide . . .” CA 120:107744 (1994).
Chen et al. “Preparation of a combinatorial library . . .” CA 134:295742 (2001).
Yu et al. “Preparation of peptides . . . ” CA 137:295252 (2002).
Silverman “The organic chemistry of drug design and drug action” Academic Press, (1993) p. 357-358.
Bundgaard “Design of prodrugs” Elsevier, p. 27, 31, 32 (1986).
Lendaris et al. “reach through claims . . .” Intellectual property update, v.4, No. 5, (2004).
Drustrup et al. “Prodrug forms for the sulfonamide groups.” Int. J. Pharm. 37, 87-95 (1987).

Affiliated with

Also associated with

Rating

Melanocortin receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3537369